PASITHEA THERAPEUTICS CORP. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PASITHEA THERAPEUTICS CORP. (KTTA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $4.49 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-30
- PASITHEA THERAPEUTICS CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $4.49M, a 9.82% increase from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $4.08M, a 0.00% change from fiscal 2023.
- PASITHEA THERAPEUTICS CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $4.08M, a 27.15% increase from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $3.21M, a 0.00% change from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $4.49M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $4.08M 10-K · filed 2026-03-30 | $3.47M 10-K · filed 2025-03-24 |
| 2023-12-31 | $4.08M 10-K · filed 2025-03-24 | $3.47M 10-K · filed 2024-03-29 |
| 2022-12-31 | $3.21M 10-K · filed 2024-03-29 | |
| 2021-12-31 | $3.21M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |